Fig. 1. Kaplan-Meier analysis assessing overall survival time according to gene expression in male and female liver cancer patients using TCGA databases. Kaplan-Meier survival curves comparing overall survival probability with expression levels of (A) CTNNB1, (B) IL6, (C) GLIPR1, or (D) RHOA in male and female liver cancer patients. CTNNB1, catenin beta 1; IL6, interleukin 6; GLIPR1, glioma pathogenesis-related protein 1; RHOA, Ras homolog family member A; HR, hazard ratio.
© Biomolecules & Therapeutics
